PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Blood growth factor boosts effect of exercise in peripheral artery disease

2013-11-18
(Press-News.org) Contact information: Jennifer Johnson
jrjohn9@emory.edu
404-727-5696
Emory Health Sciences
Blood growth factor boosts effect of exercise in peripheral artery disease A blood cell growth factor can boost the effects of exercise in improving mobility for patients with peripheral artery disease, a clinical study has shown.

The results are scheduled for presentation Nov. 18, 2013 at the American Heart Association Scientific Sessions meeting in Dallas (Session CS-01, Ballroom A1, 10:47 am – 10:57 am).

Researchers at Emory University School of Medicine were testing whether GM-CSF (granulocyte-macrophage colony stimulating factor), already used to restore white blood cell numbers during cancer treatment, could help heal blood vessels damaged by atherosclerosis.

In peripheral artery disease, patients' legs have trouble getting enough blood during exercise, leading to impaired mobility and pain after exertion. The primary outcome measured in the study was how long participants could walk on a treadmill two months after a four-week course of either GM-CSF injections or placebo.

"We saw a modest increase in treadmill walking time for patients treated with GM-CSF, compared to placebo," says study leader Arshed Quyyumi, MD, professor of medicine at Emory University School of Medicine and co-director of the Emory Clinical Cardiovascular Research Institute.

"However, we also saw something encouraging. The patients who strongly responded to GM-CSF, measured by the levels of progenitor cells in their blood, also saw more benefit in terms of maximum walking time. Changes in the dose and duration of GM-CSF treatment could possibly enhance therapeutic benefit, and this needs more investigation."

At the start of the study, both groups could walk on a treadmill for a maximum of about five minutes. On average, study participants who received GM-CSF had their maximum walking time increase almost a minute (53 seconds) more than the placebo group, although the difference was not statistically significant.

Both groups of patients were encouraged to walk several times per day, and both GM-CSF and placebo groups saw increases in their ability to walk (30 percent increase for GM-CSF compared to 21 percent increase for placebo). A total of 159 patients participated in the phase II study, all at Emory-affiliated medical centers from 2010 to 2012.

GM-CSF is thought to act by moving progenitor cells out of the bone marrow so that they can replenish the linings of blood vessels. In the Emory study, there was some variability in how much individual patients responded to GM-CSF.

Some patients who received GM-CSF experienced above-average increases in the levels of progenitor cells, defined as carrying the marker CD34. They also experienced greater increases in their ability to walk, with treadmill times in this group increasing more than two minutes on average.

Overall, the PAD patients' responses to GM-CSF were less than what has been observed in healthy individuals. This may be because of poor health and especially atherosclerosis have affected the health of the bone marrow, although people with recent heart attacks or other severe disease were excluded from the study, Quyyumi says. Participants had an average age of 64 and 37 percent of them were diabetic. However, age and diabetes did not predict patients' ability to respond to GM-CSF.

### The study was funded by a "Grand Opportunities" grant, part of the 2009 American Recovery and Reinvestment Act, from the National Heart Lung and Blood Institute (5RC2HL101515). The first author of the abstract being presented is cardiovascular research fellow Joseph Poole, MD.


ELSE PRESS RELEASES FROM THIS DATE:

Greater density of coronary artery calcium associated with lower risk of CHD, CVD

2013-11-18
Greater density of coronary artery calcium associated with lower risk of CHD, CVD Chicago – Michael H. Criqui, M.D., M.P.H., of the University of California, San Diego, and colleagues determined the independent associations of coronary artery calcium (CAC) volume and ...

Type of cell therapy does not improve walking ability for patients with peripheral artery disease

2013-11-18
Type of cell therapy does not improve walking ability for patients with peripheral artery disease Chicago – Joseph Poole, M.D., Ph.D., of the Emory University School of Medicine, Atlanta, and colleagues studied whether therapy with granulocyte-macrophage ...

Therapy using stem cells, bone marrow cells, appears safe for patients with ischemic cardiomyopathy

2013-11-18
Therapy using stem cells, bone marrow cells, appears safe for patients with ischemic cardiomyopathy Chicago – Alan W. Heldman, M.D., of the University of Miami Miller School of Medicine, and colleagues conducted a study to examine the safety of transendocardial ...

Addition of certain drugs to diuretic therapy does not improve kidney function

2013-11-18
Addition of certain drugs to diuretic therapy does not improve kidney function Chicago – Horng H. Chen, M.B.B.Ch., of the Mayo Clinic, Rochester, Minn., and colleagues conducted a randomized trial to determine whether, as compared with placebo, the addition of ...

More than skin deep: New layer to the body's fight against infection

2013-11-18
More than skin deep: New layer to the body's fight against infection The layers of skin that form the first line of defence in the body's fight against infection have revealed a unanticipated secret. The single cell type that was thought to be behind ...

Bacteria use lethal cytotoxins to evade antibiotic treatment

2013-11-18
Bacteria use lethal cytotoxins to evade antibiotic treatment In spite of the fact that the first antibiotics were discovered almost a century ago, infectious diseases such as tuberculosis, encephalitis and meningitis are still serious diseases for humans in the ...

Manipulation of protein could help stop spread of cancer cells

2013-11-18
Manipulation of protein could help stop spread of cancer cells DNA regulator stops cancer cells in their tracks Understanding how and why cancer cells move away from their original location is important to find ways to stop the spread of the disease. ...

Vismodegib in basal cell carcinoma: Added benefit not proven

2013-11-18
Vismodegib in basal cell carcinoma: Added benefit not proven Hardly any patient-relevant outcomes were investigated/ studies without control groups The drug vismodegib (trade name: Erivedge) is approved for the treatment of patients ...

Amber provides new insights into the evolution of the Earth's atmosphere

2013-11-18
Amber provides new insights into the evolution of the Earth's atmosphere Scientists encounter big challenges when reconstructing atmospheric compositions in the Earth's geological past because of the lack of useable sample material. One of the few ...

Would an 'anti-ketamine' also treat depression?

2013-11-18
Would an 'anti-ketamine' also treat depression? Yes, says a new study in Biological Psychiatry Philadelphia, PA, November 18, 2013 – Thirteen years ago, an article in this journal first reported that the anesthetic medication, ketamine, showed evidence of producing ...

LAST 30 PRESS RELEASES:

Cercus electric stimulation enables cockroach with trajectory control and spatial cognition training

Day-long conference addresses difficult to diagnose lung disease

First-ever cardiogenic shock academy features simulation lab

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

[Press-News.org] Blood growth factor boosts effect of exercise in peripheral artery disease